This week on Contemporary OB/GYN®: Jan. 24 to Jan. 28

The effect of eating disorders in pregnancy on neurodevelopmental risk in infants

Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.

Read now

Pembrolizumab plus lenvatinib show promise in advanced endometrial carcinoma

The latest trial results showed statistically significant improvements in overall survival and progression-free survival.

Read now

Agile Therapeutics partners with Afayxs to expand access to Twirla®

Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla®) transdermal system.

Read now

Check back soon for additional updates.